University of Thessaly (UTH)
Προσδιορισμός της ιαιμίας από τον ιό της ηπατίτιδας Β (HBV) με τη χρήση πραγματικού χρόνου PCR σε ασθενείς που βρίσκονται σε θεραπεία υποκατάστασης για χρόνια νεφρική ανεπάρκεια
Abstract
dc:descriptionHepatitis B virus infection (HBV) is an important cause of liver disease in the end-stage renal failure patients (ESRF) treated by haemodialysis. Occult HBV infection is characterised by undetectable serum HBsAg but detectable HBV-DNA in serum or the liver. Occult HBV infection has been reported in patients with chronic liver disease but the existing data is limited in occult HBV infection among patients on long term haemodialysis. So far, data on the prevalence and clinical significance of occult HBV infection in patients with end-stage renal failure (ESRF) patients treated by haemodialysis (HD) are missing in our country. The aims of the present study were: · Το determine the HBV-viral load in a large sample of consecutive patients with end-stage renal failure (ESRF) patients treated by haemodialysis (HD) from Central Greece. · Το determine the prevalence of occult HBV infection in a large sample of consecutive patients with end-stage renal failure (ESRF) patients treated by haemodialysis (HD) from Central Greece. Additionally, the possible clinical impact of HBV-DNA positivity in these patients (either in the context of chronic or occult HBV infection) was assessed by comparing demographic, epidemiological, biochemical and HBV, HCV, HEV, HDV, HAV and HTLV serological markers between HBV-DNA-positive and HBV-DNA-negative patients. In total, 366 ESRF patients’ sera were investigated for the presence of HBV-DNA by polymerase chain reaction (real-time PCR). Twenty of them (5.5%) were serum hepatitis B surface antigen (HBsAg) positive. HBV-DNA was detected in 15 out the 366 patients with ESRF (4.1%). HBV-DNA seropositivity was strongly associated with HBsAg (p=0.000), anti-HBe (p=0.000) and anti-HBc presence (p=0.003) and negatively associated with anti-HBs presence (p=0.000). Three out of the 15 patients with HBV-viremia were HBsAg negative (20%). Of the remaining 346 HBsAg negative ESRF patients, the prevalence of occult HBV-infection was 0.9%. Occult HBV-DNA detection was not associated with a specific marker of past HBV infection. HBV-viremia is lower than the results of standard HBsAg testing would suggest in ESRF patients. The demographic, biochemical, and/or serological features of HBV-DNA positive subjects do not help to distinguish these individuals from those who are HBV-DNA negative. Even though, this cross-sectional study in HD patients could not demonstrate that occult HBV infection is a major health problem in Central Greece, close consideration and evaluation for the presence of occult HBV infection should be performed at least for those who are candidate for kidney transplantation, as the subsequent immunosuppression could have detrimental effects on the index patient. We believe that longitudinal studies are essential in an attempt to further clarify the clinical significance and outcome of occult HBV infection, as well as the possibility of nosocomial transmission of occult HBV infection in this setting.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Μηνά, Παρασκευή
- Mina, Paraskevi
Subjects
dc:subject × 16- Προσδιορισμός
- Ιαιμία
- Ηπατίτιδα B (HBV)
- Πραγματικού χρόνου PCR
- Θεραπεία υποκατάστασης
- Χρόνια νεφρική ανεπάρκεια (ΧΝΑ)
- Detection
- Viremia
- Hepatitis B virus (HBV)
- Real time PCR
- Haemodialysis
- Chronic renal failure (CRF)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18579